<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8"/>
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
  <meta name="title" content="Santhera and ReveraGen Announce New 2 . 5 - year Treatment Data with Vamorolone in Duchenne ... "/>
  <meta name="description" content="Two leading drugs have revealed the safety, tolerability and long-term treatment benefits of a controversial muscle dystrophy drug in patients with Duchenne muscular dystrophic disorder (DMD) which have been given the green light for treatment."/><meta name="robots" content="index,follow"/><link rel="canonical" href="https://datosabiertos.com/open_data/2021-04-28/santhera-and-reveragen-announce-new-2-5-year-treatment-data-with-vamorolone-in-duchenne/">
  <link rel="icon" href="/img/favicon.ico"/>

  <title>Santhera and ReveraGen Announce New 2 . 5 - year Treatment Data with Vamorolone in Duchenne ...  - Open Data</title>

  <link rel="preload" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css" as="style" onload="this.onload=null;this.rel='stylesheet'">
  <noscript><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css" integrity="sha384-xOolHFLEh07PJGoPkLv1IbcEPTNtaed2xpHsD9ESMhqIYd0nLMwNLD69Npy4HI+N" crossorigin="anonymous"></noscript>

  
  <link rel="stylesheet" href="/css/custom.css">
</head>

<body>
  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MXMNS5J"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
  <main role="main" class="container">
    
    <header class="site-header py-3">
      <div class="row flex-nowrap justify-content-between align-items-center">
        <div class="col pt-1">
          <a class="site-header-name" href="/">
            <h1 class="site-header-name">Open Data</h1>
          </a>
        </div>
      </div>
    </header>
    

    
    <div class="container nav-bar">
      <div class="row nav">
        <a class="col-md-auto p-2" href="/es/">ES</a>
        <a class="col-md-auto p-2" href="/">EN</a>
      </div>
    </div>
    

    <div class="row">

      
      <div class="col">
        
<div class="content is-medium">
  <p class="article_item">
    <a href="https://apnews.com/press-release/globe-newswire/health-business-bb8297aff977a89f10ffac3de6e6285b" target="_new">Santhera and ReveraGen Announce New 2 . 5 - year Treatment Data with Vamorolone in Duchenne ... </a>
    <p>Two leading drugs have revealed the safety, tolerability and long-term treatment benefits of a controversial muscle dystrophy drug in patients with Duchenne muscular dystrophic disorder (DMD) which have been given the green light for treatment.</p>
    <b style="font-weight: bold;">Source: <i>apnews.com</i></b>
    <br/>Published on <a href="/open_data/2021-04-28/">2021-04-28</a>
  </p>
</div>

    <div class="content is-medium">
        <h3>Related news</h3>
        <ul>
        
            <li><a href="/open_data/2022-06-09/2022-06-09--state-comptroller-dinapoli-releases-audits">State Comptroller DiNapoli Releases Audits</a></li>
        
            <li><a href="/open_data/2022-09-21/2022-09-21--schlumberger-launches-enterprise-data-solution">Schlumberger Launches Enterprise Data Solution</a></li>
        
            <li><a href="/open_data/2021-05-20/2021-05-20--virtual-panel-how-open-source-is-helping-to-change-the-world">Virtual Panel : How Open - Source is Helping to Change the World</a></li>
        
            <li><a href="/open_data/2022-10-26/2022-10-26--state-comptroller-dinapoli-releases-audits">State Comptroller DiNapoli Releases Audits</a></li>
        
            <li><a href="/open_data/2022-08-16/2022-08-16--evergreen-partners-with-local-ontario-conservation-authority-and-peel-region-for-next-phase-of-ai-for-the-resilient-city">Evergreen partners with local Ontario conservation authority and Peel Region for next phase of AI for the Resilient City</a></li>
        
            <li><a href="/open_data/2022-07-24/2022-07-24--planning-and-statistics-authority-announces-policy-of-publishing-official-statistics">Planning and Statistics Authority announces policy of publishing official statistics</a></li>
        
            <li><a href="/open_data/2022-11-02/2022-11-02--state-comptroller-dinapoli-releases-audits">State Comptroller DiNapoli Releases Audits</a></li>
        
            <li><a href="/open_data/2022-07-24/2022-07-24--psa-announces-policy-of-publishing-official-statistics">PSA announces policy of publishing official statistics</a></li>
        
            <li><a href="/open_data/2021-09-29/2021-09-29--enel-x-launches-the-first-circular-city-index-for-italian-municipalities">Enel X launches the first  Circular City Index  for Italian municipalities</a></li>
        
            <li><a href="/open_data/2022-02-01/2022-02-01--how-police-can-use-smart-technology-to-improve-community-relations">How police can use smart technology to improve community relations</a></li>
        
            <li><a href="/open_data/2022-04-05/2022-04-05--questions-and-answers-on-revised-eu-rules-on-industrial-emissions">Questions and Answers on Revised EU rules on Industrial Emissions</a></li>
        
            <li><a href="/open_data/2022-04-07/2022-04-07--staff-on-salaries-over-ps100k-at-watford-and-hertfordshire-councils-st-albans-harpenden-review">Staff on salaries over 100k at Watford and Hertfordshire councils | St Albans &amp; Harpenden Review</a></li>
        
            <li><a href="/open_data/2021-04-29/santhera-and-reveragen-announce-new-2-5-year-treatment-data-with-vamorolone-in-duchenne-muscular-dystrophy">Santhera and ReveraGen Announce New 2 . 5 - year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy</a></li>
        
            <li><a href="/open_data/2021-10-04/2021-10-04--digital-twins-a-comprehensive-solution-or-hopeful-vision">Digital Twins : A Comprehensive Solution or Hopeful Vision ? </a></li>
        
            <li><a href="/open_data/2021-06-30/2021-06-30--algorithm-and-blues-avoiding-the-traps-in-new-tech">Algorithm and blues : avoiding the traps in new tech</a></li>
        
        </ul>
    </div>
<div class="row">
  <div class="col-md-6">
    
      <a href="/open_data/2021-04-28/santhera-and-reveragen-announce-new-2-5-year-treatment-data-with-vamorolone-in-duchenne-muscular-dystrophy/">&laquo;&nbsp;Santhera and ReveraGen Announce New 2 . 5 - year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy</a>
    
  </div>
  <div class="col-md-6 text-right">
    
      <a href="/open_data/2021-04-28/red-hat-launches-openshift-platform-plus-alongside-new-managed-cloud-services/">Red Hat launches OpenShift Platform Plus alongside new managed cloud services &nbsp;&raquo;</a>
    
  </div>
</div>

    </div>
  </main>

  <footer class="site-footer">

    <div class="row">
      <div class="col-md-3"></div>
      <div class="col-md-3 col-md-center">

      </div>
      <div class="col-md-3 col-md-center">

      </div>
    </div>
  </div>
  </footer>

  
  

  
  
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
            new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
            j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
            '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
            })(window,document,'script','dataLayer','GTM-MXMNS5J');
        </script>
    

  
  <script src="https://cdn.jsdelivr.net/npm/jquery@3.5.1/dist/jquery.slim.min.js" integrity="sha384-DfXdz2htPH0lsSSs5nCTpuj/zy4C+OGpamoFVy38MVBnE+IbbVYUew+OrCXaRkfj" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js" integrity="sha384-Fy6S3B9q64WdZWQUiU+q4/2Lc9npb8tCaSX9FK7E8HnRr0Jz8D6OP9dO5Vg3Q9ct" crossorigin="anonymous"></script>

</body>

</html>
